Research ArticleClinical Studies
Low-dose Cytarabine plus Aclarubicin for Patients with Previously Untreated Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Ineligible for Standard-dose Cytarabine plus Anthracycline
TOSHIHIRO FUKUSHIMA, HIROSHI KAWABATA, TOSHIOKI SAWAKI, TOMOMI SATOH, TAKUJI NAKAMURA, HARUKA IWAO, AKIO NAKAJIMA, TOMOYUKI SAKAI, MIYUKI MIKI, YOSHIMASA FUJITA, MASAO TANAKA, TAKAFUMI KAWANAMI, YASUFUMI MASAKI, TOSHIRO OKAZAKI and HISANORI UMEHARA
Anticancer Research April 2012, 32 (4) 1347-1353;
TOSHIHIRO FUKUSHIMA
HIROSHI KAWABATA
TOSHIOKI SAWAKI
TOMOMI SATOH
TAKUJI NAKAMURA
HARUKA IWAO
AKIO NAKAJIMA
TOMOYUKI SAKAI
MIYUKI MIKI
YOSHIMASA FUJITA
MASAO TANAKA
TAKAFUMI KAWANAMI
YASUFUMI MASAKI
TOSHIRO OKAZAKI
In this issue
Low-dose Cytarabine plus Aclarubicin for Patients with Previously Untreated Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Ineligible for Standard-dose Cytarabine plus Anthracycline
TOSHIHIRO FUKUSHIMA, HIROSHI KAWABATA, TOSHIOKI SAWAKI, TOMOMI SATOH, TAKUJI NAKAMURA, HARUKA IWAO, AKIO NAKAJIMA, TOMOYUKI SAKAI, MIYUKI MIKI, YOSHIMASA FUJITA, MASAO TANAKA, TAKAFUMI KAWANAMI, YASUFUMI MASAKI, TOSHIRO OKAZAKI, HISANORI UMEHARA
Anticancer Research Apr 2012, 32 (4) 1347-1353;
Low-dose Cytarabine plus Aclarubicin for Patients with Previously Untreated Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Ineligible for Standard-dose Cytarabine plus Anthracycline
TOSHIHIRO FUKUSHIMA, HIROSHI KAWABATA, TOSHIOKI SAWAKI, TOMOMI SATOH, TAKUJI NAKAMURA, HARUKA IWAO, AKIO NAKAJIMA, TOMOYUKI SAKAI, MIYUKI MIKI, YOSHIMASA FUJITA, MASAO TANAKA, TAKAFUMI KAWANAMI, YASUFUMI MASAKI, TOSHIRO OKAZAKI, HISANORI UMEHARA
Anticancer Research Apr 2012, 32 (4) 1347-1353;
Jump to section
Related Articles
- No related articles found.